Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

Open access
Abraham, William T., Kuck, Karl-Heinz, Goldsmith, Rochelle L., Lindenfeld, JoAnn, Reddy, Vivek Y., Carson, Peter E., Mann, Douglas L., Saville, Benjamin, Parise, Helen, Chan, Rodrigo, Wiegn, Phi, Hastings, Jeffrey L., Kaplan, Andrew J., Edelmann, Frank, Luthje, Lars, Kahwash, Rami, Tomassoni, Gery F., Gutterman, David D., Stagg, Angela, Burkhoff, Daniel, Hasenfuß, Gerd·2018·JACC: Heart Failure

Abstract

OBJECTIVES: This study sought to confirm a subgroup analysis of the prior FIX-HF-5 (Evaluate Safety and Efficacy of the OPTIMIZER System in Subjects With Moderate-to-Severe Heart Failure) study showing that cardiac contractility modulation (CCM) improved exercise tolerance (ET) and quality of life in patients with ejection fractions between 25% and 45%. BACKGROUND: CCM therapy for New York Heart Association (NYHA) functional class III and IV heart failure (HF) patients consists of nonexcitatory electrical signals delivered to the heart during the absolute refractory period. METHODS: (primary endpoint), Minnesota Living With Heart Failure questionnaire, NYHA functional class, and 6-min hall walk were measured at baseline and at 12 and 24 weeks. Bayesian repeated measures linear modeling was used for the primary endpoint analysis with 30% borrowing from the FIX-HF-5 subgroup. Safety was assessed by the percentage of patients free of device-related adverse events with a pre-specified lower bound of 70%. RESULTS: /kg/min, satisfying the primary endpoint. Minnesota Living With Heart Failure questionnaire (p < 0.001), NYHA functional class (p < 0.001), and 6-min hall walk (p = 0.02) were all better in the treatment versus control group. There were 7 device-related events, yielding a lower bound of 80% of patients free of events, satisfying the primary safety endpoint. The composite of cardiovascular death and HF hospitalizations was reduced from 10.8% to 2.9% (p = 0.048). CONCLUSIONS: CCM is safe, improves exercise tolerance and quality of life in the specified group of HF patients, and leads to fewer HF hospitalizations. (Evaluate Safety and Efficacy of the OPTIMIZER System in Subjects With Moderate-to-Severe Heart Failure; NCT01381172).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2018.04.010

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 273

Metadata

Authors
Abraham, W. T., Kuck, K.-H., Goldsmith, R. L., Lindenfeld, J., Reddy, V. Y., Carson, P. E., Mann, D. L., Saville, B., Parise, H., Chan, R., Wiegn, P., Hastings, J. L., Kaplan, A. J., Edelmann, F., Luthje, L., Kahwash, R., Tomassoni, G. F., Gutterman, D. D., Stagg, A., Burkhoff, D., & Hasenfuß, G.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2018-10
Volume
6
Issue
10
Pages
874-883
ISSN
2213-1779 (ISSN-L)
OpenAlex
W2801842505
Cited by
273
References
18
FWCI
15.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. https://app.cochat.ai/papers/10.1016/j.jchf.2018.04.010
The paper
Abraham, W. T., Kuck, K.-H., Goldsmith, R. L., Lindenfeld, J., Reddy, V. Y., Carson, P. E., Mann, D. L., Saville, B., Parise, H., Chan, R., Wiegn, P., Hastings, J. L., Kaplan, A. J., Edelmann, F., Luthje, L., Kahwash, R., Tomassoni, G. F., Gutterman, D. D., Stagg, A., . . . Hasenfuß, G. (2018). A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2018.04.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.